Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

References

• AdesmanARThe diagnosis and management of attention-deficit/hyperactivity disorder in pediatric patientsPrim Care Companion J Clin Psychiatry200132667715014618
   PubMedGoogle Scholar
• MannuzzaSKleinRGLong-term prognosis in attention-deficit/hyperactivity disorderChild Adolesc Psychiatr Clin N Am20009371172610944664
   PubMed Web of Science ®Google Scholar
• MindeKLewinDWeissGLavigueurHDouglasVSykesEThe hyperactive child in elementary school: a 5 year, controlled, followupExcept Child19713832152215119943
   PubMed Web of Science ®Google Scholar
• BiedermanJNewcornJSprichSComorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disordersAm J Psychiatry199114855645772018156
   PubMed Web of Science ®Google Scholar
• BiedermanJAttention-deficit/hyperactivity disorder: a life-span perspectiveJ Clin Psychiatry199859Suppl 7S4S16
   PubMed Web of Science ®Google Scholar
• SpencerTJBiedermanJMickEAttention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiologyJ Pediatr Psychol200732663164217556405
   PubMed Web of Science ®Google Scholar
• AntshelKMHargraveTMSimonescuMKaulPHendricksKFaraoneSVAdvances in understanding and treating ADHDBMC Med201197221658285
   PubMed Web of Science ®Google Scholar
• RöslerMCasasMKonofalEBuitelaarJAttention deficit hyperactivity disorder in adultsWorld J Biol Psychiatry201011568469820521876
   PubMed Web of Science ®Google Scholar
• FaraoneSVBiedermanJSpencerTAttention-deficit/hyperactivity disorder in adults: an overviewBiol Psychiatry200048192010913503
   PubMed Web of Science ®Google Scholar
• AdlerLCohenJDiagnosis and evaluation of adults with attention-deficit/hyperactivity disorderPsychiatr Clin North Am20042718720115063992
   PubMed Web of Science ®Google Scholar
• WilensTEMorrisonNRPrinceJAn update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsExpert Rev Neurother201111101443146521955201
   PubMed Web of Science ®Google Scholar
• FaraoneSVBiedermanJMickEThe age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychol Med20062159165
   Web of Science ®Google Scholar
• KleinRGMannuzzaSOlazagastilMARClinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years laterArch Gen Psychiatry201269121295130323070149
   PubMed Web of Science ®Google Scholar
• NakamuraSOhnishiMUchiyamaSEpidemiological survey of adult attention deficit hyperactivity disorder (ADHD) in JapanJpn J Psychiatr Treat201328155162
   Google Scholar
• NylanderLHolmqvistMGustafsonLGillbergCAttention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in adult psychiatry. A 20-year register studyNordic J Psychiatry2013675344350
   PubMed Web of Science ®Google Scholar
• KanbayashiYSaitoKKitaMJapanese Guideline for Diagnosis and Treatment of AD/HD [in Japanese]TokyoJiho2003
   Google Scholar
• SaitoKWatanabeKJapanese Guideline for Diagnosis and Treatment of AD/HD, Revised Edition [in Japanese]TokyoJiho2006
   Google Scholar
• HirataYGotoTTakitaYLong-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorderAsia Pac Psychiatry20146329230124376099
   PubMed Web of Science ®Google Scholar
• TakahashiMTakitaYGotoTAn open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorderPsychiatry Clin Neurosci2011651556321265936
   PubMed Web of Science ®Google Scholar
• TakahashiMGotoTTakitaYChungSWangYShur-Fen GauSOpen-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorderAsia Pac Psychiatry201461627023857916
   PubMed Web of Science ®Google Scholar
• MatsuiAAzumaJWitcherJWPharmacokinetics, safety, and tolerability of atomoxetine and effect of CYP2D6*10/*10 genotype in healthy Japanese menJ Clin Pharmacol201252338840321543662
   PubMed Web of Science ®Google Scholar
• CamporealeAUpadhyayaHRamos-QuirogaJASafety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorderEur J Psychiatry2013273206224
   Web of Science ®Google Scholar
• WernickeJFFariesDGirodDCardiovascular effects of atomoxetine in children, adolescents, and adultsDrug Saf2003261072974012862507
   PubMed Web of Science ®Google Scholar
• TakedaTPsychopharmacology for attention deficit/hyperactivity disorder in JapanCurr Attention Dis Rep2009112128
   Google Scholar
• DoshiJAHodgkinsPKahleJEconomic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJ Am Acad Adolesc Psychiatry201251109901002
   PubMed Web of Science ®Google Scholar
• Japan Medical Data Center [homepage on the Internet]TokyoJapan Medical Data Center Co., Ltd. Available from: https://www.jmdc.co.jp/en/about/database.htmlAccessed July 6, 2017
   Google Scholar
• CharlsonMECharlsonREPetersonJCMarinopoulosSSBriggsWMHollenbergJPThe Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patientsJ Clin Epidemiol200861121234124018619805
   PubMed Web of Science ®Google Scholar
• KirinoEImagawaHGotoTMontgomeryWSociodemographics, comorbidities, healthcare utilization and work productivity in Japanese patients with adult ADHDPLoS One2015107e013223326147097
   PubMed Web of Science ®Google Scholar
• SecnikKSwensenALageMJComorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorderPharmacoeconomics20052319310215693731
   PubMed Web of Science ®Google Scholar
• PerwienARHallJSwensenASwindleRStimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorderJ Manag Care Pharm200410212212915032561
   PubMedGoogle Scholar
• BiedermanJFaraoneSMilbergerSA prospective 4-year follow-up study of attention-deficit hyperactivity and related disordersArch Gen Psychiatry19965354374468624187
   PubMed Web of Science ®Google Scholar
• KooijJSHussMAshersonPDistinguishing comorbidity and successful management of adult ADHDJ Atten Disord2012165 Suppl3S19S22498754
   PubMed Web of Science ®Google Scholar
• DasDCherbuinNButterworthPAnsteyKJEastealSA population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adultsPLoS One201272e3150022347487
   PubMed Web of Science ®Google Scholar
• McIntoshDKutcherSBinderCLevittAFalluARosenbluthMAdult ADHD and comorbid depression: a consensus-derived diagnostic algorithm for ADHDNeuropsychiatr Dis Treat2009513715019557108
   PubMed Web of Science ®Google Scholar
• ChangKNayarDHoweMRanaMAtomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorderJ Child Adolesc Psychopharmacol200919554755119877979
   PubMed Web of Science ®Google Scholar
• BarkleyRAChallenges in diagnosing adults with ADHDJ Clin Psychiatry20086912e3619203486
   PubMed Web of Science ®Google Scholar
• BuckleyPFFosterAEPatelNCWermertAAdherence to Mental Health TreatmentNew York, NYOxford University Press2009
   Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• GotoTHirataYTakitaYEfficacy and safety of atomoxetine hydrochloride in Asian adults with ADHD: a multinational 10-week randomized double-blind placebo-controlled Asian studyJ Atten Disord201721210010924203774
   PubMed Web of Science ®Google Scholar
• GarbeEMikolajczykRTBanaschewskiTDrug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort studyJ Child Adolesc Psychopharmacol201222645245823234588
   PubMed Web of Science ®Google Scholar
• SobanskiELeppämäkiSBusheCBerggrenLCasillasMDeberdtWPatterns of long-term and short-term responses in adult patients with attention-deficit/hyperactivity disorder in a completer cohort of 12 weeks or more with atomoxetineEur Psychiatry20153081011102026512449
   PubMed Web of Science ®Google Scholar
• GajriaKLuMSikiricaVGrevenPZhongYQinPXieJAdherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder–a systematic literature reviewNeuropsychiatr Dis Treat201410154325187718
   PubMed Web of Science ®Google Scholar
• ChengYSShyuYCLeeSYYuanSSYangCJYangKCLeeTLTrend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in TaiwanNeuropsychiatr Dis Treat20171364328280346
   PubMed Web of Science ®Google Scholar
• NevilleSEBoyeKSMontgomeryWSIwamotoKOkamuraMHayesRPDiabetes in Japan: a review of disease burden and approaches to treatmentDiabetes Metab Res Rev200925870571619795421
   PubMed Web of Science ®Google Scholar
• ChenHJLeeYJYehGCLinHCAssociation of attention-deficit/hyperactivity disorder with diabetes: a population-based studyPediatr Res2013734 Pt 149249623329200
   PubMed Web of Science ®Google Scholar
• KrauseICleperRKovalskiYSinaiLDavidovitsMChanges in behavior as an early symptom of renovascular hypertension in childrenPediatr Nephrol200924112271227419444479
   PubMed Web of Science ®Google Scholar
• Levitt KatzLESwamiSAbrahamMNeuropsychiatric disorders at the presentation of type 2 diabetes mellitus in childrenPediatr Diabetes200562848915963035
   PubMed Web of Science ®Google Scholar
• OECDLength of Hospital Stay (Indicator)2017 Available from: https://data.oecd.org/healthcare/length-of-hospital-stay.htmAccessed November 21, 2017
   Google Scholar
• WassersteinJDiagnostic issues for adolescents and adults with ADHDJ Clin Psychol200561553554715723419
   PubMed Web of Science ®Google Scholar